Daytrana ADHD Patch May Cause Permanent Skin Color ChangesDaytrana ADHD Patch May Cause Permanent Skin Color Changes
The methylphenidate patch Daytrana for ADHD may cause permanent skin color loss, the FDA warns. News Alerts (Source: Medscape Psychiatry Headlines)
Source: Medscape Psychiatry Headlines - June 25, 2015 Category: Psychiatry Tags: Psychiatry News Alert Source Type: news
FDA Warns of Permanent Loss of Skin Pigmentation with ADHD Patch (FREE)
By Kristin J. Kelley
Edited by Susan Sadoughi, MD
The methylphenidate patch (Daytrana) — used to treat attention-deficit/hyperactivity disorder — may cause loss of … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - June 25, 2015 Category: Primary Care Source Type: news
Daytrana Patch (methylphenidate transdermal system): Drug Safety Communication - Permanent Skin Color Changes
New warning added to drug label to describe risk of chemical leukoderma.
chemical leukoderma, have been associated with the use of the Daytrana patch. (Source: FDA MedWatch)
Source: FDA MedWatch - June 24, 2015 Category: American Health Source Type: news
Attenuated neural processing of risk in young adults at risk for stimulant dependence - Reske M, Stewart JL, Flagan TM, Paulus MP.
OBJECTIVE: Approximately 10% of young adults report non-medical use of stimulants (cocaine, amphetamine, methylphenidate), which puts them at risk for the development of dependence. This fMRI study investigates whether subjects at early stages of stimulant... (Source: SafetyLit: All (Unduplicated))
Source: SafetyLit: All (Unduplicated) - June 19, 2015 Category: Global & Universal Tags: Age: Adolescents Source Type: news
Generic ADHD Drugs Remain on the Market, Despite Lack of Therapeutic Equivalence (FREE)
By Amy Orciari Herman
Edited by Susan Sadoughi, MD, and Richard Saitz, MD, MPH, FACP, FASAM
Two generic versions of the attention-deficit/hyperactivity drug Concerta (methylphenidate hydrochloride extended-release tablets) continue to be available months after the FDA deemed them … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - June 18, 2015 Category: Primary Care Source Type: news
Methylphenidate-based NPS: a review of the evidence of use and harm - Iverson L.
Methylphenidate-based NPS
Methylphenidate is a licensed stimulant pharmaceutical and is controlled in the UK as a Class B controlled drug. The methylphenidate-related materials being marketed as NPS have psychoactive effects so similar to the parent com... (Source: SafetyLit: All (Unduplicated))
Source: SafetyLit: All (Unduplicated) - April 17, 2015 Category: Global & Universal Tags: Alcohol and Other Drugs Source Type: news
Example of an investigation of an "emergent" phenomenon in addiction vigilance: the case of methylphenidate - Micallef J, Frauger E, Palmaro A, Boucherie Q, Lapeyre Mestre M.
Abuse of and addiction to medication are a major public health issue which is evolving fast, in particular in countries like France, one of the largest consumers of medication in Europe. As a single source of information is not generally sufficient to meas... (Source: SafetyLit: All (Unduplicated))
Source: SafetyLit: All (Unduplicated) - April 17, 2015 Category: Global & Universal Tags: Alcohol and Other Drugs Source Type: news
Experts Weigh In On The Ethics Of Using Brain-Enhancing Drugs
By: Tanya Lewis
Published: March 26, 2015 08:00am ET
Boosting a person's smarts through drugs or electrical or magnetic stimulation of the brain is becoming an increasingly widespread practice. Now, bioethicists are weighing in, saying that while such cognitive enhancement is neither bad nor good, it deserves more research.
In the past, "there have been many arguments that suggest one should take an ethical stance for or against cognitive enhancement" of healthy individuals, said Amy Gutmann, chairwoman of the Presidential Commission for the Study of Bioethical Issues, which released the second part of a report...
Source: Science - The Huffington Post - March 27, 2015 Category: Science Source Type: news
Differential effects of MDMA and methylphenidate on social cognition - Schmid Y, Hysek CM, Simmler LD, Crockett MJ, Quednow BB, Liechti ME.
Social cognition is important in everyday-life social interactions. The social cognitive effects of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') and methylphenidate (both used for neuroenhancement and as party drugs) are largely unknown. We investig... (Source: SafetyLit: All (Unduplicated))
Source: SafetyLit: All (Unduplicated) - March 11, 2015 Category: Global & Universal Tags: Alcohol and Other Drugs Source Type: news
Stimulant May Speed Antidepressant Response Time in ElderlyStimulant May Speed Antidepressant Response Time in Elderly
Methylphenidate combined with the antidepressant citalopram significantly reduced time to depression remission in elderly patients. Medscape Medical News (Source: Medscape Psychiatry Headlines)
Source: Medscape Psychiatry Headlines - March 4, 2015 Category: Psychiatry Tags: Psychiatry News Source Type: news
Study suggests combination drug therapy to treat depression in the elderly
FINDINGS
This new study by researchers at UCLA found that the combination of Ritalin (methylphenidate) and Celexa (citalopram) can accelerate and improve the overall antidepressant effects of the medications in the elderly. Most patients who responded to the combination achieved remission in the first month. The researchers had also hoped to find that the combination would work more quickly and be tolerated better by this elderly population than either drug alone. They found that the combination was working faster, but the side effects and cognitive benefits did not differ between the groups.
IMPACT
Geriatric depression is...
Source: UCLA Newsroom: Health Sciences - February 24, 2015 Category: Universities & Medical Training Source Type: news
Methylphenidate and the risk of trauma - Man KK, Chan EW, Coghill D, Douglas I, Ip P, Leung LP, Tsui MS, Wong WH, Wong IC.
BACKGROUND AND OBJECTIVE: Children and adolescents with attention-deficit/hyperactivity disorder (ADHD) are prone to sustaining trauma that requires emergency department (ED) admission. Methylphenidate (MPH) can reduce ADHD symptoms and may thus theoretica... (Source: SafetyLit: All (Unduplicated))
Source: SafetyLit: All (Unduplicated) - December 30, 2014 Category: Global & Universal Tags: Age: Adolescents Source Type: news
Methylphenidate Reduces Injuries in Kids With ADHDMethylphenidate Reduces Injuries in Kids With ADHD
Children with attention-deficit hyperactivity disorder (ADHD) who take methylphenidate are less likely to present for emergency treatment of trauma, a new study finds. Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 19, 2014 Category: Consumer Health News Tags: Psychiatry News Source Type: news
Adolescent exposure to cocaine, amphetamine, and methylphenidate cross-sensitizes adults to methamphetamine with drug- and sex- specific effects - Shanks RA, Ross JM, Doyle HH, Helton AK, Picou BD, Schulz J, Tavares C, Bryant S, Dawson BL, Lloyd SA.
The increasing availability, over-prescription, and misuse and abuse of ADHD psychostimulant medications in adolescent populations necessitates studies investigating the long-term effects of these drugs persisting into adulthood. Male and female C57Bl/6J m... (Source: SafetyLit: All (Unduplicated))
Source: SafetyLit: All (Unduplicated) - December 19, 2014 Category: Global & Universal Tags: Age: Adolescents Source Type: news
With stimulant, kids with ADHD less likely to injure themselves
(Reuters Health) – When kids with attention-deficit hyperactivity disorder (ADHD) are taking methylphenidate, a stimulant drug, they are less likely to end up in the emergency room with a trauma injury, a new study finds. (Source: Reuters: Health)
Source: Reuters: Health - December 18, 2014 Category: Consumer Health News Tags: healthNews Source Type: news
